Studies in chemotherapy. VII. A theory of the relation of structure to activity of sulfanilamide type compounds
Studies in chemotherapy. VII. A theory of the relation of structure to activity of sulfanilamide type compounds
复制标题
DOI:
10.1021/ja01264a055
复制
发表时间:
1942-07-01
影响因子:
15
通讯作者:
Roblin, RO Jr
中科院分区:
文献类型:
--
作者:
Bell, PH;Roblin, RO Jr
The bacteriostatic activity of over 100 sulfanilamide-type compounds was determined with Escherichia coli in synthetic medium at pH 7. The acid dissociation constants of the same compounds were also measured. A plot of acid constants vs. bacteriostatic activity gives a smooth curve which passes through a maximum as the acid strength increases. The theory is developed that the more negative the SO2 group of an N''-substrtuted sulfanilamide derivative, the greater is its bacteriostatic power. The elec-tronegativity of this SO2 group is greatly increased by loss of a proton from the adjacent N atom. Therefore the ionic form of any sulfonamide should be much more active than the molecular form. Thus bacteriostatic power (measured at pH 7) increases with acid strength until the compound is essentially completely ionized. Acid strength is proportioned to the electron attracting power of the N'' substituent (R). As this increases, the R group tends to attract electrons away from the SO2 group, thus decreasing its electronega-tivity. Therefore, the more acidic the sulfonamide, the less negative the SO2 group of the ionic and molecular forms and the less the bacteriostatic activity of either form. Thus further increases in acidity beyond that needed to effect approximately complete ionization of the compound decrease bacteriostatic activity. Some interesting implications of the theory are discussed, such as the reversal of the bacteriostatic power of various compounds by altering the pH at which testing is carried out. Knowing something about the relative electron attracting power of the N''-substituent it is possible for the first time to predict the bacteriostatic power of a new sulfanilamide derivative.